AltiVate Anatomic Shoulder System for the following Part Numbers: 1. Part # 520-08-00, Rev. C., 2. Part # 520-10-000, 3. Part # 520-12-000, 4. Part # 520-14-000, 5. Part # 520-16-000 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
AltiVate Anatomic Shoulder System for the following Part Numbers: 1. Part # 520-08-00, Rev. C., 2. Part # 520-10-000, 3. Part # 520-12-000, 4. Part # 520-14-000, 5. Part # 520-16-000
Lot Codes / Batch Numbers
Part number/ Lot number: 1. 520-08-000 / 85OU1108, 85OU1110, 85OU1111, 2. 520-10-000 / 851U1256, 851U1257, 851U1258, 851U1259, 3. 520-12-000 / 852U1402, 852U1393, 852U1404, 852U1395, 852U1398A, 852U1405, 852U1397, 852U1391, 852U1400, 852U1398, 852U1407, 852U1396, 852U1406, 4. 520-14-000 / 853U1234, 853U1240, 853U1241A, 853U1238, 853U1239, 853U1237, 853U1241, 5. 520-16-000 / 854U1076, 854U1077
Products Sold
Part number/ Lot number: 1. 520-08-000 / 85OU1108; 85OU1110; 85OU1111, 2. 520-10-000 / 851U1256; 851U1257; 851U1258; 851U1259, 3. 520-12-000 / 852U1402; 852U1393; 852U1404; 852U1395; 852U1398A, 852U1405; 852U1397; 852U1391; 852U1400; 852U1398; 852U1407; 852U1396; 852U1406, 4. 520-14-000 / 853U1234; 853U1240; 853U1241A; 853U1238; 853U1239; 853U1237; 853U1241, 5. 520-16-000 / 854U1076; 854U1077
A medical device manufacturer is recalling AltiVate Anatomic Shoulder System for the following Part Numbers: 1. Part # 520-08-00, Rev. C., 2. due to Complaints have been received concerning the humeral stem failing to mate with the broach handles for a shoulder device. This could result in delay o. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Complaints have been received concerning the humeral stem failing to mate with the broach handles for a shoulder device. This could result in delay of procedure or revision surgery.
Recommended Action
Per FDA guidance
On June 28, 2021, Encore Medical (DJO) issued a "Urgent Medical Device Recall" Notification to affected consignees, via E-Mail. In addition to informing consignees about the recall devices, the firm asked consignees to take the following actions by July 19, 2021: 1. Review your stock for the affected products and lot numbers and quarantine the items until returned. 2. Communicate the affected parts, lots, and quantities that you have in stock to your sales Agent and arrange to return all affected, unused product to your sales Agent. 3. Report any adverse events related to this issue to DJO Customer Service (1-800-456-8696). Please also note that Adverse reactions or quality problems experienced with the use of this product MAY be reported to the FDAs MedWatch Adverse Event reporting program either online, by regular mail or by fax. 4. Complete the Medical Device Recall acknowledge and receipt form (including all information in the yellow-highlighted cells) with all available information and return by e-mail to julie.baker@djoglobal.com and david.evans1@djoglobal.com by July 31, 2021.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AL, AZ, AR, CA, CO, FL, GA, HI, IL, IN, KY, LA, ME, MD, MI, MN, MS, MO, MT, NV, NM, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA, WV, PR
Page updated: Jan 10, 2026